Ramachandran Murali
VP of Research and Development, Kairos Pharma, LTD.
Companies
- Kairos Pharma, LTD.VP of Research and Development Sep 24, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Kairos Pharma, LTD. KAPA299,529 shares2$171.5K at $0.57Oct 8, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 8, 2025Granted 152,672 shares of Kairos Pharma, LTD.2
- Jan 1, 2025Granted 14,000 shares of Kairos Pharma, LTD.3
- Nov 25, 2024Bought 200 shares at $1.59 of Kairos Pharma, LTD.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 24, 2025
- 4SEC EDGARForm 4 filed Nov 25, 2024